GlassScriptPhysician profile
Gaurav Arora
NPI 1538128616
$11,769.30
in general payments reported to CMS, 2019-2025
39 companies · $6,865 in 2025
The $6,865 reported for 2025 was more than what 92% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,579 · 2020: $75.44 · 2021: $364 · 2022: $721 · 2023: $600 · 2024: $1,565 · 2025: $6,865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,325 · Food and Beverage: $3,036 · Travel and Lodging: $653 · Education: $15.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,325.00 |
| Food and Beverage | $3,036.26 |
| Travel and Lodging | $652.95 |
| Education | $15.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $5,977.95 | 2024-2025 | Omvoh |
| Abbvie INC. | $1,374.65 | 2019-2025 | Rinvoq, Skyrizi, Linzess |
| Echosens North America, INC. | $865.76 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $298.00 | 2019-2025 | Entyvio |
| Regeneron Healthcare Solutions, INC. | $294.13 | 2022-2025 | Dupixent |
| Madrigal Pharmaceuticals | $244.12 | 2024-2025 | Rezdiffra, Resmetirom |
| Ipsen Biopharmaceuticals, INC | $235.08 | 2024-2025 | Iqirvo, Bylvay |
| Medtronic, INC. | $225.01 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $204.95 | 2019-2025 | Trulance, Xifaxan, Relistor |
| Phathom Pharmaceuticals, INC. | $195.44 | 2024-2025 | Voquezna |
| Celgene Corporation | $180.76 | 2022-2024 | Zeposia |
| Intercept Pharmaceuticals, INC. | $180.41 | 2019-2023 | Ocaliva |
| Genzyme Corporation | $144.64 | 2022-2025 | |
| Pfizer INC. | $139.20 | 2019-2022 | |
| Boston Scientific Corporation | $132.64 | 2019-2023 | Wavewriter Alpha Prime 16 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $128.75 | 2025 | Omvoh |
| Vivus LLC | $104.58 | 2023-2025 | Pancreaze, Qsymia |
| Ardelyx, INC. | $99.40 | 2024-2025 | Ibsrela |
| Aimmune Therapeutics, INC. | $97.55 | 2024-2025 | Zenpep |
| Shionogi INC | $90.34 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $90.00 | 2019 | |
| Nestle Healthcare Nutrition INC. | $68.15 | 2021-2023 | |
| Intra-Sana Laboratories | $46.63 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Gilead Sciences, INC. | $35.05 | 2023-2024 | |
| Ironwood Pharmaceuticals, INC | $32.65 | 2019-2021 | |
| Qol Medical, LLC | $30.50 | 2025 | Sucraid |
| Janssen Biotech, INC. | $29.18 | 2022 | |
| Merck Sharp & Dohme LLC | $23.36 | 2021 | |
| Alexion Pharmaceuticals, INC. | $22.28 | 2019 | |
| Shield Therapeutics INC | $21.35 | 2023 | |
| Redhill Biopharma INC. | $21.24 | 2024 | Talicia |
| Pinnacle Biologics, INC | $20.20 | 2024 | Photofrin |
| Ethicon US, LLC | $19.55 | 2022 | |
| Abbott Laboratories | $18.37 | 2025 | Cardiomems |
| Daiichi Sankyo INC. | $18.29 | 2019 | |
| Ferring Pharmaceuticals INC. | $16.78 | 2022 | |
| Capsovision, INC. | $16.61 | 2024 | Capsocam Plus |
| Evoke Pharma, INC. | $14.98 | 2023 | Gimoti |
| Endogastric Solutions, INC | $10.77 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.